-
Treatments
- Do you think it might be cancer?
- Imaging and diagnosing cancer
- Cancer treatment
- New drug treatments and clinical trials
- Remote Appointments at Docrates Cancer Center
- International cooperation
- Health and Recovery Center
- Accommodation
- Costs and financial information
- Patient satisfaction
- For New Patients
- Laboratory and ward
- Cancer types
- Patient stories
- Costs and financial information
- For New Patients
- Booking
Hypofractionated stereotactic radiotherapy in the treatment of metastases
Stereotactic body radiation therapy (SBRT) is well suited for the palliative treatment of metastases in the brain, liver, lungs and sometimes also in the bones.
Hypofractionated stereotactic radiotherapy effectively destroys local metastases. Radiotherapy is often given for metastases after chemotherapy to stabilise the disease. In this way, the disease can be controlled without further chemotherapy.
Oncologists in Finland have long been using hypofractionated stereotactic radiotherapy with great success. In the treatment of metastases, the patient may be given 1 to 5 hypofractionated high-dose radiotherapy doses depending on the size, location and previous treatment of the metastases.
SBRT is used for the treatment of urological and gynaecological cancers, lung, intestinal, liver and breast cancer, and for the treatment of metastases of other cancers. In certain cases, SBRT can also be used as primary treatment for cancer.
Read more
Colorectal cancer is a common but rarely talked-about disease
Colorectal cancer is the second most common cancer in Finland, and its level of incidence is increasing. Lifestyles and the...
Read more
Breakthroughs in follow-up cancer diagnostics: Recurring cancer can be detected before it reaches full speed
20.4.2023 | A liquid biopsy using markers released into the bloodstream by cancer cells can reveal the possible recurrence of...
Read more
Internal radiotherapy is an effective method of treatment for metastatic prostate cancer
14.3.2023 | Docrates Cancer Center studied the effectiveness of 177Lu-PSMA treatment with a 4-week treatment interval for patients with metastatic...
Read more
The number of insured patients has more than tripled in five years
9.3.2023 | In 2022, nearly 30% of revenue generated by Docrates Cancer Center’s Finnish patients came from insurance company customers,...
Read moreWhy come to Docrates Cancer Center?
- Top cancer experts and effective treatments without delay.
- Individual care. You have your own care team - your doctor and your nurse.
- Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
- Experience in treating international patients from over 60 countries. Multilingual personnel.
Contact us!
Mon-Thu 8 am-6 pm, Fri 8 am-4 pm (local time)
